Jifeng Yu
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
- Phagocytosis and Immune Regulation
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 21
- Immunotherapy and Immune Responses 11
- Immune Cell Function and Interaction 7
- Co-authors
- Yongping Song (16 shared papers)Zhongxing Jiang (35 shared papers)Wenzhi Tian (7 shared papers)Haowei Sun (7 shared papers)Yingmei Li (14 shared papers)Weijie Cao (10 shared papers)Haizhou Xing (12 shared papers)Dingming Wan (14 shared papers)
- Journals
- Experimental Hematology and Oncology (5 papers)Biomarker Research (4 papers)Blood (3 papers)Scientific Reports (3 papers)Advanced Science (3 papers)
- Partner nations
- ChinaUnited StatesIndonesia
In The Last Decade
Jifeng Yu
74 papers receiving 1.8k citations
Jifeng Yu's Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 694
- Oncology 545
- Hematology 203
- Animal Science and Zoology 135
- Infectious Diseases 170
Countries citing papers authored by Jifeng Yu
This map shows the geographic impact of Jifeng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jifeng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jifeng Yu more than expected).
Fields of papers citing papers by Jifeng Yu
This network shows the impact of papers produced by Jifeng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jifeng Yu. The network helps show where Jifeng Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Jifeng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Targeting CD47 for cancer immunotherapy Hit paper breakdown → | 2021 | 240 |
| 2 | 2020 | 179 | |
| 3 | 2022 | 124 | |
| 4 | 2011 | 121 | |
| 5 | 2022 | 109 | |
| 6 | 2022 | 81 | |
| 7 | 2021 | 77 | |
| 8 | 2022 | 71 | |
| 9 | 2022 | 61 | |
| 10 | 2018 | 60 | |
| 11 | Targeting TIGIT for cancer immunotherapy: recent advances and future directions Hit paper breakdown → | 2024 | 54 |
| 12 | 2020 | 53 | |
| 13 | 2020 | 52 | |
| 14 | 2020 | 50 | |
| 15 | 2024 | 33 | |
| 16 | 2021 | 32 | |
| 17 | 2008 | 27 | |
| 18 | 2024 | 20 | |
| 19 | 2019 | 19 | |
| 20 | 2023 | 18 |
About Jifeng Yu
Jifeng Yu is a scholar working on Molecular Biology, Immunology, Hematology, Infectious Diseases and Oncology, having authored 77 papers that have together received 1.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (14 papers), Immunotherapy and Immune Responses (11 papers), Virus-based gene therapy research (10 papers), Animal Virus Infections Studies (9 papers), Viral gastroenteritis research and epidemiology (9 papers), Immune Cell Function and Interaction (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). The work is most often cited by research in Immunology (694 citations), Oncology (545 citations), Hematology (203 citations), Animal Science and Zoology (135 citations) and Infectious Diseases (170 citations). Jifeng Yu has collaborated with scholars based in China, United States and Indonesia. Frequent co-authors include Yongping Song, Zhongxing Jiang, Wenzhi Tian, Haowei Sun, Yingmei Li, Weijie Cao, Haizhou Xing, Dingming Wan, Haohao Yin and Bangguo Zhou. Their work appears in journals such as Experimental Hematology and Oncology, Biomarker Research, Blood, Scientific Reports and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.